Report: Indonesia halts repatriation of 38 Malaysian students after all test positive for Covid-19 | Malay Mail

United States News News

Report: Indonesia halts repatriation of 38 Malaysian students after all test positive for Covid-19 | Malay Mail
United States Latest News,United States Headlines
  • 📰 malaymail
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 86%

Report: Indonesia halts repatriation of 38 Malaysian students after all test positive for Covid-19

Wednesday, 29 Apr 2020 08:09 PM MYTA medical officer wearing protective gear takes a blood sample from a member of the Tablighi Jamaat, during a test for coronavirus disease in Temanggung, Central Java, Indonesia April 20, 2020.— Reuters pic

“The 29 Malaysian students have to stay here in the village because they have to wait for the PCR test results,” Saif was quoted as saying. The report said that the Malaysian Embassy in Jakarta had planned to repatriate more than 150 Malaysian students who initially wanted to stay put and spend the fasting month in the village.

The boarding school is reportedly also a base for the Jamaah Tabligh group, which has held events in Malaysia, India and South Sulawesi that have been linked to several Covid-19 cases in the respective regions.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

malaymail /  🏆 1. in MY

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Four Asean nations among 38 to get Avigan drug from Japan for clinical trialFour Asean nations among 38 to get Avigan drug from Japan for clinical trialBANGKOK (The Nation/ANN): Japan is preparing to send Avigan, a drug used for treating influenza, to 38 countries this week, with four Asean countries -- the Philippines, Malaysia, Indonesia and Myanmar -- joining the trial for Covid-19 patients.
Read more »

Report: Lakers return US$4.6m to Covid-19 relief fund | Malay MailReport: Lakers return US$4.6m to Covid-19 relief fund | Malay MailLOS ANGELES, April 28 — The Los Angeles Lakers have returned about US$4.6 million (RM20 million) obtained from a US government program meant to help small businesses recover from the coronavirus pandemic shutdown, ESPN reported Monday. The NBA club, valued by Forbes magazine at US$4.4 billion,...
Read more »

Covid-19: 29 Malaysian students fail rapid test in East Java, barred from boarding flight home | Malay MailCovid-19: 29 Malaysian students fail rapid test in East Java, barred from boarding flight home | Malay MailJAKARTA, April 28 ― Twenty-nine out of 164 Malaysian students in East Java heading back to Malaysia were found to be positive when undergoing a Covid-19 rapid test and thus were barred from boarding a flight from Surabaya. All students of Pondok Pesantren Al-Fatah Temboro Magetan in East Java...
Read more »

Selangor community Covid-19 test detects eight asymptomatic positive cases | Malay MailSelangor community Covid-19 test detects eight asymptomatic positive cases | Malay MailSHAH ALAM, April 29 ― The Covid-19 community screening exercise conducted by the Selangor government in six red zones detected eight out of 10 positive cases were asymptomatic. Selangor Mentri Besar, Datuk Seri Amirudin Shari said the targeted community screening was carried out from April 11 to...
Read more »

Plenitude shuts down three hotels, downsizes others on Covid-19 | Malay MailPlenitude shuts down three hotels, downsizes others on Covid-19 | Malay MailKUALA LUMPUR, April 27 — Plenitude Bhd is closing the operations of three hotels, namely Mercure Penang Beach and The Gurney Resort Hotel and Residences, both in Penang, and Travelodge Ipoh, Perak with immediate effect, and downsizing operations in the other hotels owned by it. This decision is a...
Read more »

Closely watched arthritis drug disappoints in Covid-19 trial | Malay MailClosely watched arthritis drug disappoints in Covid-19 trial | Malay MailWASHINGTON, April 28 — An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said yesterday. Kevzara, which is made by Regeneron and Sanofi, does not attack the novel coronavirus but instead...
Read more »



Render Time: 2025-03-09 15:43:28